Home/Filings/5/0000907254-25-000012
5//SEC Filing

Laycock Willoughby B. 5

Accession 0000907254-25-000012

CIK 0000907254other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 10:30 AM ET

Size

22.9 KB

Accession

0000907254-25-000012

Insider Transaction Report

Form 5
Period: 2024-12-31
Laycock Willoughby B.
DirectorSVP-Res. Design/Mrkt Research
Transactions
  • Other

    Common Stock

    2024-12-20+541.0673,451.068 total
Holdings
  • Director Stock Option

    Exercise: $43.89From: 2021-05-07Exp: 2031-05-07Common Stock (2,500 underlying)
    2,500
  • Employee Stock Option

    Exercise: $33.79From: 2023-05-12Exp: 2033-05-12Common Stock (10,000 underlying)
    10,000
  • Phantom Stock

    Common Stock (3,798.803 underlying)
    3,798.803
  • Performance Shares

    Exercise: $0.00From: 2029-05-17Exp: 2029-05-17Common Stock (500 underlying)
    500
  • Director Stock Option

    Exercise: $55.71From: 2019-05-03Exp: 2029-05-03Common Stock (2,500 underlying)
    2,500
  • Director Stock Option

    Exercise: $50.00From: 2020-04-24Exp: 2030-04-24Common Stock (2,500 underlying)
    2,500
  • Employee Stock Option

    Exercise: $43.89From: 2021-05-07Exp: 2031-05-07Common Stock (10,000 underlying)
    10,000
  • Director Stock Option

    Exercise: $47.90From: 2022-05-13Exp: 2032-05-13Common Shares (2,500 underlying)
    2,500
  • Employee Stock Option

    Exercise: $47.90From: 2022-05-13Exp: 2032-05-13Common Stock (10,000 underlying)
    10,000
  • Common Stock

    (indirect: By Spouse)
    249.952
  • Employee Stock Option

    Exercise: $55.71From: 2019-05-03Exp: 2029-05-03Common Stock (5,000 underlying)
    5,000
  • Employee Stock Option

    Exercise: $50.00From: 2020-04-24Exp: 2030-04-24Common Stock (10,000 underlying)
    10,000
  • Director Stock Option

    Exercise: $33.79From: 2023-05-12Exp: 2033-05-12Common Stock (2,500 underlying)
    2,500
Footnotes (8)
  • [F1]This is a correction to the balance previously reported on the Form 4 filed on May 21, 2024.
  • [F2]Shares received from a trust in which the reporting person was a beneficiary but not the trustee. The transfer reflects a change in the form of ownership, with the reporting person now directly holding the shares. No consideration was paid by the reporting person in connection with transaction.
  • [F3]This is a correction to the balance previously reported on the Form 4 filed on May 21, 2024. Previously, shares (319.059) were reported to be indirect beneficial ownership from the reporting person's spouse. These shares were directly owned by the reporting person and upon correcting the balance and nature of ownership, now total 3,451.068
  • [F4]The options vest 25% per year over four years from the date of grant.
  • [F5]Phantom shares are issuable pursuant to the Issuer's Deferred Compensation Plan for Directors under its 2004 Stock Plan, as amended (the "Deferred Compensation Plan"). Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in cash or common stock, at the election of the reporting person, upon the reporting person's termination of service.
  • [F6]The conversion of the phantom stock into shares of the Issuer's common stock is governed by the Deferred Compensation Plan and the reporting person's Deferred Fee Election Agreement.
  • [F7]Balance increased by July 31, 2024 and October 31, 2024 Dividend Reinvestment Plan awards totaling 113.314 shares.
  • [F8]The performance share award provides for the grant of restricted shares of Common Stock on each of the five anniversaries of May 17, 2024 in equal annual installments. The number of restricted shares of such grant that vest, if any, is (i) subject to cliff-vesting on May 17, 2029, and (2) achievement of performance criteria relating to the Companys target Funds from Operations available to common stockholders and noncontrolling interests (FFO) measured against an FFO amount included in the budget established by the Board of Directors annually prior to the start of such calendar year.

Issuer

SAUL CENTERS, INC.

CIK 0000907254

Entity typeother

Related Parties

1
  • filerCIK 0001771496

Filing Metadata

Form type
5
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 10:30 AM ET
Size
22.9 KB